Search

You searched for "patient"

1088 results found

Dual therapy for OAB in children

1 May 2018 | | URO - Functional / Reconstructive Urology, URO - Paediatrics
Overactive bladder (OAB) is a disorder frequently encountered by the paediatric urologist. Morin et al. report the results of the first known study on the efficacy of mirabegron (a β3 adrenoceptor agonist) as add-on therapy in paediatric patients with refractory...
Journal of Urology cover

Psychosocial and sexual outcomes after surgery for proximal hypospadias

5 November 2019 | | URO - Andrology, URO - Paediatrics
Andersson et al. report the psychosocial and sexual outcomes for adolescents treated previously for proximal hypospadias. They hypothesised outcomes would be negatively affected compared to patients with distal hypospadias or age-matched controls (Swedish population registry). Participants answered a web-based questionnaire...
BJUI International cover photo

Supranormal function on MAG-3 – what is its significance and how to predict?

9 March 2020 | | URO - Paediatrics
Differential renal function (DRF) on MAG-3 scans is typically used in patients with pelvic ureteric junction obstruction (PUJ obstruction). Supranormal DRF is when the kidney with PUJO has higher DRF than the normal contralateral kidney. The authors in this study...

‘One team’: our experience teaching catheter care and difficult urethral catheterisation to NHS Nightingale Hospital London volunteer staff members

4 September 2020 | | URO - Functional / Reconstructive Urology, URO - Technology
The NHS Nightingale Hospital London was launched in response to the COVID-19 pandemic. In mid-March 2020, the predicted scale of the pandemic was uncertain and there was concern that COVID-19 might overwhelm existing intensive care unit (ICU) capacity within weeks....

Ejaculatory dysfunction: a review of current practice and guidelines

1 January 2015 | | URO - Andrology
Introduction The ejaculatory process is paramount to procreation in nature. It is a complex orchestration of physiology that results in emission of the ejaculate into the posterior urethra followed by ejection of those fluids from the urethra and orgasm. The...

The role of embolisation in urology

3 September 2024 | | URO - Functional / Reconstructive Urology, URO - Urologic Oncology
Case 1 An 86–year–old male presented with visible haematuria and suprapubic pain. He had a history of diabetes, heart failure, benign prostatic hypertrophy, aortic valve replacement, deep vein thrombosis (DVT) and atrial fibrillation (AF) and was anticoagulated on a non-VKA...

Should it be a mandatory requirement for medical students to receive the COVID-19 vaccine to attend clinical attachments?

11 August 2021 | | URO - Core Urology
The vast majority of medical students have positive attitudes towards the COVID-19 vaccine for themselves and patients, however, what about the small inevitable minority who resist it? Should they be prevented from attending clinical attachments in the NHS? It is...

Prostate cancer series: diagnostics 2

4 March 2025 | | URO - Urologic Oncology, URO - Core Urology, URO - Uroradiology
- Click here for Part 1 - A 68-year-old male was referred to the two-week wait prostatic clinic with a serum prostate specific antigen (PSA) of 17. He had no bothersome lower urinary tract symptoms, relevant past medical history or...

Female and functional

13 March 2023 | | URO - Core Urology
Case 1 A 65-year-old woman presents with an 18-month history of “recurrent urinary tract infections” (rUTI). She is otherwise fit and well with no underlying medical problems and no lower urinary tract symptoms. What is the definition of a UTI...

Use of MRI in the evaluation of prostate cancer: part 2

1 March 2015 | | URO - Urologic Oncology, URO - Uroradiology
Diffusion weighted imaging and contrast enhanced imaging Introduction Magnetic resonance imaging (MRI) is widely used in localisation, staging and post-treatment follow-up of prostate cancer. In the previous issue, we discussed the usefulness of MRI in depicting prostate anatomy and pairing...

Neuroendocrine bladder tumour

5 February 2025 | | URO - Urologic Oncology
A 75-year-old male with a history of prostate adenocarcinoma (T3b/T4 N1 M1b, Gleason 4+3) on Zoladex® and enzalutamide, presented with visible haematuria. His prostate specific antigen (PSA) had decreased from 43.6ug/L in December 2022 to 0.02ug/L. He also had a...

In conversation with Paula Allchorne

10 March 2022 | URO - Core Urology
We were delighted to catch up with Paula Allchorne, Chair of the European Association of Urology Nurses (EAUN) about her career in urological nursing and her plans for the association. Can you tell us a little bit about what led...